News | January 19, 2025
Heraeus acquires Umicore’s Platinum API business outside of South America
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
The company ensures a reliable and strong portfolio at competitive prices without compromising on excellent quality
Increases speed to market for drug developers working on nucleic acid therapeutics
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
We now rank 3rd in pharmaceutical production by volume and 14th by value
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
Subscribe To Our Newsletter & Stay Updated
